GPD1L在肾透明细胞癌中的表达及其临床意义(4)
[7] Sulaiman SA， Abu N， Ab-Mutalib NS， Low TY， Jamal R. Signatures of gene expression， DNA methylation and microRNAs of hepatocellular carcinoma with vascular invasion. Future Oncol， 2019， 15(22)：2603-2617.
[8] Barata PC， Rini BI. Treatment of renal cell carcinoma： current status and future directions. CA Cancer J Clin， 2017， 67(6)：507-524.
[9] Li QK， Pavlovich CP， Zhang H， Kinsinger CR， Chan DW. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC)： a critical step towards the personalized care of renal cancers. Semin Cancer Biol， 2019， 55：8-15.
[10] Kelly TJ， Souza AL， Clish CB， Puigserver P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol， 2011， 31(13)：2696-2706.
[11] Sch?del J， Grampp S， Maher ER， Moch H， Ratcliffe PJ， Russo P， Mole DR. Hypoxia， Hypoxia-inducible transcription factors， and renal cancer. Eur Urol， 2016， 69(4)：646-657.
[12] Costales MG， Haga CL， Velagapudi SP， Childs-Disney JL， Phinney DG， Disney MD. Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit. J Am Chem Soc， 2017， 139(9)：3446-3455.
(收稿日期：2019-09-18)
(本文編辑：林燕薇), 百拇医药(刘仁?许晓明?罗勇?冯源发?周瑞?钟惟德)
[8] Barata PC， Rini BI. Treatment of renal cell carcinoma： current status and future directions. CA Cancer J Clin， 2017， 67(6)：507-524.
[9] Li QK， Pavlovich CP， Zhang H， Kinsinger CR， Chan DW. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC)： a critical step towards the personalized care of renal cancers. Semin Cancer Biol， 2019， 55：8-15.
[10] Kelly TJ， Souza AL， Clish CB， Puigserver P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol， 2011， 31(13)：2696-2706.
[11] Sch?del J， Grampp S， Maher ER， Moch H， Ratcliffe PJ， Russo P， Mole DR. Hypoxia， Hypoxia-inducible transcription factors， and renal cancer. Eur Urol， 2016， 69(4)：646-657.
[12] Costales MG， Haga CL， Velagapudi SP， Childs-Disney JL， Phinney DG， Disney MD. Small molecule inhibition of microRNA-210 reprograms an oncogenic hypoxic circuit. J Am Chem Soc， 2017， 139(9)：3446-3455.
(收稿日期：2019-09-18)
(本文編辑：林燕薇), 百拇医药(刘仁?许晓明?罗勇?冯源发?周瑞?钟惟德)